ArticleFrontiers in immunology2022

Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade.

Jie Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.